Clinical Trials Directory

Trials / Completed

CompletedNCT03292939

Progestrone and Doppler Indices

The Effect of Vaginal Progestrone on Fetal and Maternal Doppler Indices

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to assess the effect of vaginal progestrone on fetal and maternal doppler indices

Detailed description

A complete Doppler flow assessment of the maternal and fetal circulation was conducted by an independent investigator blinded to the treatment, before and 48 hours after the first administration of 400mg of vaginal progesterone, Voluson E8 (GE Healthcare, Zipf, Austria) ultrasound machine,equipped with a 3.5- MHz curvilinear abdominal transducer with color imaging capabilities, was used in all cases.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTA complete Doppler flow assessment of the maternal and fetal circulationA complete Doppler flow assessment of the maternal and fetal circulation was conducted by an independent investigator blinded to the treatment, 48 hours after receiving 400mg of vaginal progestrone .Voluson E8 (GE Healthcare, Zipf, Austria) ultrasound machine ,equipped with a 3.5-MHz curvilinear abdominal transducer with color imaging capabilities, was used in all cases.

Timeline

Start date
2017-01-01
Primary completion
2017-10-01
Completion
2017-10-01
First posted
2017-09-26
Last updated
2017-10-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03292939. Inclusion in this directory is not an endorsement.